Cognition Therapeutics, Inc.
CGTX
$1.20
$0.021.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 10.61M | 10.66M | 11.13M | 11.73M | 12.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.80M | 44.85M | 52.94M | 53.64M | 53.97M |
| Operating Income | -47.80M | -44.85M | -52.94M | -53.64M | -53.97M |
| Income Before Tax | -23.49M | -27.99M | -32.99M | -33.30M | -33.97M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -23.49 | -27.99 | -32.99 | -33.30 | -33.97 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -23.49M | -27.99M | -32.99M | -33.30M | -33.97M |
| EBIT | -47.80M | -44.85M | -52.94M | -53.64M | -53.97M |
| EBITDA | -47.73M | -44.77M | -52.84M | -53.53M | -53.86M |
| EPS Basic | -0.34 | -0.48 | -0.66 | -0.73 | -0.87 |
| Normalized Basic EPS | -0.21 | -0.30 | -0.42 | -0.46 | -0.55 |
| EPS Diluted | -0.35 | -0.49 | -0.68 | -0.75 | -0.88 |
| Normalized Diluted EPS | -0.21 | -0.30 | -0.42 | -0.46 | -0.55 |
| Average Basic Shares Outstanding | 292.07M | 248.15M | 210.62M | 186.99M | 158.90M |
| Average Diluted Shares Outstanding | 292.07M | 248.15M | 210.62M | 186.99M | 158.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |